Vicus Capital’s Idexx Laboratories IDXX Stock Holding History

Vicus Capital’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$257K	Buy	+493	New	+$270K	0.02%	251
2026 Q1	–	Sell	-300	Closed	-$203K	–	263
2025 Q4	$203K	Buy	+300	New	+$204K	0.02%	256
2024 Q2	–	Sell	-389	Closed	-$210K	–	290
2024 Q1	$210K	Buy	+389	New	+$213K	0.02%	259
2023 Q2	–	Sell	-495	Closed	-$248K	–	216
2023 Q1	$248K	Buy	+495	New	+$237K	0.03%	181
2022 Q1	–	Sell	-417	Closed	-$221K	–	234
2021 Q4	$221K	Buy	+417	New	+$262K	0.02%	210
2021 Q2	–	Sell	-409	Closed	-$200K	–	194
2021 Q1	$200K	Hold	409	–	–	0.02%	229
2020 Q4	$204K	Buy	+409	New	+$183K	0.03%	221

Other funds holding IDXX

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

Montrusco Bolton Investments Montreal, Quebec, Canada $5.77B AUM 24.61% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.8B AUM 33.92% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Williams Jones Wealth Management New York $8.94B AUM 17.99% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return

Vicus Capital's IDXX Position: Q3 2026 in Review

Vicus Capital opened a new position in Idexx Laboratories (IDXX) in Q3 2026: 493 shares worth $257K. The stake represents 0.02% of the portfolio and ranks #251 among its holdings. This is a return to the name: Vicus Capital previously reported a position in IDXX as recently as Q4 2025.

Vicus Capital first reported a position in IDXX in Q4 2020 and has held it in 7 quarters since. 682 funds tracked by Wall St. Rank hold IDXX as of Q3 2026.

Vicus Capital held 493 shares of Idexx Laboratories worth $257K as of Q3 2026.
Idexx Laboratories was a new Vicus Capital position in Q3 2026.
Idexx Laboratories made up 0.02% of Vicus Capital's portfolio in Q3 2026, its #251 holding.
Vicus Capital first reported a position in Idexx Laboratories in Q4 2020 and has held it in 7 quarters since.
682 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2026.

Based on Vicus Capital's 13F filing for Q3 2026, filed 5 Nov 2026.